Search
Brainsway Ltd
BWAYAdd to Watchlist
15.190USD
-0.100-0.65%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
304.05MMarket Cap
33.12P/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
-0.65%
5 Days
+4.90%
1 Month
+6.45%
6 Months
-21.25%
Year to Date
-20.14%
1 Year
+14.73%
Key Figures
15.355Open
15.750High
81.61KVolume
33.12P/E TTM
13.69P/E Dynamic
--Dividend TTM
0.41%Turnover Ratio
15.290Prev. Close
15.100Low
897.30KTurnover
104.09P/E Static
3.80P/B
0.00%Div Yield TTM
8.06%ROA
17.35252wk High
1.75Volume Ratio
2.92MNet Profit
20.02MShares
0.4586EPS TTM
1.21Beta
11.75%ROE
5.00552wk Low
4.25%Amplitude
75.17%Gross Margin
304.05MMarket Cap
2.86Reward/Risk
2.50%Risk Rate
TradingKey Stock Score of Brainsway Ltd
Currency: USD Updated: 2026-07-02Key Insights
Brainsway Ltd's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 77 out of 204 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Strong Buy, with the highest price target at 17.50.In the medium term, the stock price is expected to trend up.The company has been performing well in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Brainsway Ltd's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
Brainsway Ltd Highlights
StrengthsRisks
Brainsway Ltd is an Israel-based company engaged in the development and marketing of medical devices for the treatment of various neurological and psychopathological disorders. The Company primarily offers Transcranial Magnetic Stimulation (TMS) system, a medical device that enables direct non-invasive activation of deep brain structures. Its TMS system uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. TMS system is used in various clinical applications including: major depressive disorders, obsessive-compulsive disorder, smoking addiction and others various psychiatric, neurological, and addiction disorders.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 64.31% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 52.23M.
Fairly Valued
The company’s latest PE is 33.12, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 12.27M shares, decreasing 20.62% quarter-over-quarter.
Held by Bill Nygren | OAKMX
Star Investor Bill Nygren | OAKMX holds 82.90K shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of 0.12.
Analyst Rating
Based on
2
analysts
Strong Buy
Current Rating
17.500
Target Price
+14.45%
Upside Space
Brainsway Ltd News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Brainsway Ltd Info
Brainsway Ltd is an Israel-based company engaged in the development and marketing of medical devices for the treatment of various neurological and psychopathological disorders. The Company primarily offers Transcranial Magnetic Stimulation (TMS) system, a medical device that enables direct non-invasive activation of deep brain structures. Its TMS system uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. TMS system is used in various clinical applications including: major depressive disorders, obsessive-compulsive disorder, smoking addiction and others various psychiatric, neurological, and addiction disorders.
Ticker SymbolBWAY
CompanyBrainsway Ltd
CEOLevy (Hadar)
Websitehttps://www.brainsway.com/
Related Instruments
-0.37%
+1.91%
+3.48%
+5.87%
+2.10%
-0.10%
+4.19%
+5.03%
+4.30%
+0.25%
+3.65%
+4.74%
+2.79%
+2.59%
-3.06%
+3.40%
+3.76%
+1.10%
+0.28%
-2.09%Popular Instruments
52852.900
+10.400 (+0.02%)
29669.900
+358.500 (+1.22%)
7507.800
+36.300 (+0.49%)
14963.000
+160.000 (+1.08%)
69676.000
+1528.000 (+2.24%)
6412.400
+59.600 (+0.94%)
68.683
+0.339 (+0.50%)
308.630
+14.250 (+4.84%)
194.830
-2.750 (-1.39%)
4174.610
+52.700 (+1.28%)
FAQs
What is the current price of Brainsway Ltd (BWAY)?
The current price of Brainsway Ltd (BWAY) is 15.19.
What is the symbol of Brainsway Ltd?
The ticker symbol of Brainsway Ltd is BWAY.
What is the 52-week high of Brainsway Ltd?
The 52-week high of Brainsway Ltd is 17.35.
What is the 52-week low of Brainsway Ltd?
The 52-week low of Brainsway Ltd is 5.00.
What is the market capitalization of Brainsway Ltd?
The market capitalization of Brainsway Ltd is 304.05M.
Is Brainsway Ltd (BWAY) currently rated as Buy, Hold, or Sell?
According to analysts, Brainsway Ltd (BWAY) has an overall rating of STRONG BUY, with a price target of 17.50.
What is the Earnings Per Share (EPS TTM) of Brainsway Ltd (BWAY)?
The Earnings Per Share (EPS TTM) of Brainsway Ltd (BWAY) is 0.40.